Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : VD's Model Portfolio & Discussion Thread -- Ignore unavailable to you. Want to Upgrade?

To: James Silverman who wrote (4195)	2/26/1998 1:57:00 PM
From: scaram(o)uche	Read Replies (1) \| Respond to of 9719

James: Geeeze, man, your brain is clearly not durable. What have you got in your inhaler? And what's your big hangup with Sepracure? Geeeze, you're worse than Hank with Ligund. Fred

To: James Silverman who wrote (4195)	2/26/1998 3:09:00 PM
From: Vector1	Read Replies (1) \| Respond to of 9719

<<Do you worry that Spiros albuterol is nothing more than a generic drug in a fancy package>> No the dry powder system is much more than a generic drug in a fancy package. It is easier to use, reduces the risk of microbial contamination, gives a much more accurate dose and most importanly requires almost 50% less drug to be taken. As a parent with a child that has moderate asthma this is very important. Indeed I think their second product which is the Spiros version of Beclomethasome may be bigger than Albuterol because of the desire to deliver as small a possible dose of a steriod. Beclomethasome has been shown to cause some adverse effects on growth in children so the smaller more accurate dose is important. I don't know a lot about the other companies you mentioned although I theoght KOS was years away from an NDA. V1